David A Fox

9PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityHaematological tumoursRheumatology and arthritisTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 27, 2026
CD6-Directed Immunotherapy Targets Breast Cancer Stem Cell Function and Enhances Immune-Mediated Cytotoxicity in Triple-Negative Breast Cancer.

|Aug 20, 2026
Abatacept Reduces CD319+ (SLAMF7) Cytotoxic T Cells and Cytokine Production in Systemic Sclerosis.

|Jun 26, 2026
Myeloid-Derived Suppressor Cells in Inflammatory Arthritis.

|Apr 03, 2026
Anti-Carbamylated Protein Antibodies Stabilize Carbamylated Histone H3 to Promote Synovial Activation and Neutrophil Extracellular Trap-Mediated Bone Loss in Rheumatoid Arthritis.

Shuichiro Nakabo, Norio Hanata, Eduardo Patino-Martinez

|Jan 07, 2021
Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis.

David A Fox, Steven K Lundy, Michael L Whitfield

|Feb 14, 2019
Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma.

Pei-Suen Tsou, Phillip Campbell, M Asif Amin

Pageof 2

Frequent Collaborators

2 joint publications

Yan Li

2 joint publications

Pei-Suen Tsou

2 joint publications

Laura A Cooney

2 joint publications

Mikel Gurrea-Rubio